Evidence of early ovarian aging in fragile X premutation carriers

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4569-4574

  Welt, C K ^a   Smith, P C ^a   Taylor, A E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; FRAGILE X SYNDROME; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LUTEAL PHASE; OVARY; PREMATURE AGING; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL;

ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; INHIBINS; MENSTRUAL CYCLE; MUTATION; NERVE TISSUE PROTEINS; OVARY; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEATS;

FALLOPIA;

EID: 4544294975     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0347     Document Type: Article

References (57)

1. Coulam CB, Adamson SC, Annegers JF 1986 Incidence of premature ovarian failure. Obstet Gynecol 67:604-606
2. Anasti JN 1998 Premature ovarian failure: an update. Fertil Steril 70:1-15
3. Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley Jr WF 1996 A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 81:3615-3621
4. Fryns JP 1986 The female and the fragile X. A study of 144 obligate female carriers. Am J Med Genet 23:157-169
5. Partington MW, York Moore D, Turner GM 1996 Confirmation of early menopause in fragile X carriers. Am J Med Genet 64:370-372
6. Vianna-Morgante AM, Costa SS, Pares AS, Verreschi IT 1996 FRAXA premutation associated with premature ovarian failure. Am J Med Genet 64:373-375
7. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Vieri F 1999 Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in fragile X study - preliminary data. Am J Med Genet 83:322-325
8. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJ, Stevenson RE 1994 Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51:400-402
9. Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman RJ 1991 Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet 38:269-274
10. Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B, Vieri F, Scarnato P, Gori F, Sereni A 1999 Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 84:300-303
11. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick Jr RG, Warren ST 1991 Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058
12. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP 1991 Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914
13. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL 1991 Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102
14. Jin P, Warren ST 2003 New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28:152-158
15. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST 1992 DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400
16. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL 1991 Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822
17. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ 2000 Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152
18. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ 2000 Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15
19. Nolin SL, Brown WT, Glicksman A, Houck GE, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Macpherson J, Mandel J, Matthijs G, Rousseau F, Steinbach P, Vaisanen M, von Koskull H, Sherman SL 2003 Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464
20. Nolin SL, Lewis III FA, Ye LL, Houck Jr GE, Glicksman AE, Limprasert P, Li SY, Zhong N, Ashley AE, Feingold E, Sherman SL, Brown WT 1996 Familial transmission of the FMR1 CGG repeat. Am J Hum Genet 59:1252-1261
21. Murray A, Macpherson JN, Pound MC, Sharrock A, Youings SA, Dennis NR, McKechnie N, Linehan P, Morton NE, Jacobs PA 1997 The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet 6:173-184
22. Turner G, Robinson H, Wake S, Martin N 1994 Dizygous twinning and premature menopause in fragile X syndrome. Lancet 344:1500
23. Vianna-Morgante AM 1999 Twinning and premature ovarian failure in premutation fragile X carriers. Am J Med Genet 83:326
24. Lambalk CB, De Koning CH, Braat DD 1998 The endocrinology of dizygotic twinning in the human. Mol Cell Endocrinol 145:97-102
25. Braat DD, Smits AP, Thomas CM 1999 Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study. Am J Med Genet 83:327-328
26. Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS 1999 Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 14:1217-1218
27. Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM 2001 Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 16:457-462
28. Welt CK, McNicholl D, Taylor AE, Hall JE 1999 Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84:105-111
29. Meadows KL, Pettay D, Newman J, Hersey J, Ashley AE, Sherman SL 1996 Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet 64:428-433
30. Crawford DC, Meadows KL, Newman JL, Taft LF, Pettay DL, Gold LB, Hersey SJ, Hinkle EF, Stanfield ML, Holmgreen P, Yeargin-Allsopp M, Boyle C, Sherman SL 1999 Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 64:495-507
31. Filicori M, Butler JP, Crowley Jr WF 1984 Neuroendocrine regulation of the corpus luteum in the human. J Clin Invest 73:1638-1647
32. Crowley Jr WF, Beitins IZ, Vale W, Kliman B, Rivier J, Rivier C, McArthur JW 1980 The biologic activity of a potent analogue of gonadotropin releasing hormone in normal and hypogonadotropic men. N Engl J Med 302:1052-1057
33. Taylor AE, Khoury RH, Crowley Jr WF 1994 A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation. J Clin Endocrinol Metab 79:240-247
34. Welt CK, Adams JM, Sluss PM, Hall JE 1999 Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. J Clin Endocrinol Metab 84:2163-2169
35. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley Jr WF, Schneyer AL 1994 Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 79:45-50
36. Seminara SB, Boepple PA, Nachtigall LB, Pralong FP, Khoury RH, Sluss PM, Lecain AE, Crowley Jr WF 1996 Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after short term physiologic GnRH replacement. J Clin Endocrinol Metab 81:3692-3696
37. Filicori M, Santoro N, Merriam GR, Crowley Jr WF 1986 Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 62:1136-1144
38. Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE 1998 Exaggerated free α-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 83:241-247
39. Welt CK 2002 The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14:317-323
40. Lee S, Lenton E, Sexton L, Cooke I 1988 The effect of age on the cyclical patterns of plasma LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3:851-855
41. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR 1996 Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745
42. Reame NE, Wyman TL, Phillips DJ, DeKretser DM, Padmanabhan V 1998 Net increase in stimulatory tone resulting from a decrease in inhibin-B and an increase in activin-A may contribute, in part, to the rise in follicular phase FSH of aging in cycling women. J Clin Endocrinol Metab 83:3302-3307
43. Santoro N, Adel T, Skurnick JH 1999 Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71:658-662
44. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, Dennerstein L 1998 Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 48:809-813
45. Gougeon A, Ecochard R, Thalabard JC 1994 Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod 50:653-663
46. Block E 1952 Quantitative morphological investigations of the follicular system in women. Acta Anat (Basel) 14:108-122
47. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65:1231-1237
48. Scheffer GJ, Broekmans FJM, Dorland M, Habbema JDF, Looman CWN, teVelde ER 1999 Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72:845-851
49. Lass A 2001 Assessment of ovarian reserve - is there a role for ovarian biopsy? Hum Reprod 16:1055-1057
50. Welt CK, Smith ZA, Pauler DK, Hall JE 2001 Differential regulation of inhibin A and inhibin B by LH, FSH and stage of follicle development. J Clin Endocrinol Metab 86:2531-2537
51. Welt CK, Schneyer AL 2001 Differential regulation of inhibin B and inhibin A by FSH and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 86:300-306
52. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M 1993 Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36-43
53. Hergersberg M, Matsuo K, Gassmann M, Schaffner W, Luscher B, Rulicke T, Aguzzi A 1995 Tissue-specific expression of a FMR1/β-galactosidase fusion gene in transgenic mice. Hum Mol Genet 4:359-366
54. Kenneson A, Zhang F, Hagedorn CH, Warren ST 2001 Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454
55. Murray A, Webb J, Grimley S, Conway G, Jacobs P 1998 Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35:637-640
56. Murray A, Ennis S, MacSwiney F, Webb J, Morton NE 2000 Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 8:247-252
57. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K 1995 Prevalence of carriers of premutation-size alleles of the FMRI gene - and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1018